Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04541082 |
|
Recruitment Status :
Recruiting
First Posted : September 9, 2020
Last Update Posted : April 22, 2024
|
Sponsor:
Chimerix
Collaborator:
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Chimerix
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | September 2024 |
| Estimated Study Completion Date : | February 2025 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):